Does DACOMITINIB Cause Carcinoembryonic antigen increased? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Carcinoembryonic antigen increased have been filed in association with DACOMITINIB (Vizimpro). This represents 4.1% of all adverse event reports for DACOMITINIB.
28
Reports of Carcinoembryonic antigen increased with DACOMITINIB
4.1%
of all DACOMITINIB reports
5
Deaths
2
Hospitalizations
How Dangerous Is Carcinoembryonic antigen increased From DACOMITINIB?
Of the 28 reports, 5 (17.9%) resulted in death, 2 (7.1%) required hospitalization.
Is Carcinoembryonic antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACOMITINIB. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does DACOMITINIB Cause?
Death (253)
Diarrhoea (114)
Rash (108)
Neoplasm progression (78)
Paronychia (55)
Blood pressure increased (47)
Off label use (35)
Pruritus (34)
Dyspnoea (30)
Pain (28)
What Other Drugs Cause Carcinoembryonic antigen increased?
RIBOCICLIB (143)
LETROZOLE (115)
CAPECITABINE (113)
FULVESTRANT (105)
BEVACIZUMAB (102)
REGORAFENIB (91)
OXALIPLATIN (88)
OSIMERTINIB (82)
PALBOCICLIB (78)
FLUOROURACIL (71)
Which DACOMITINIB Alternatives Have Lower Carcinoembryonic antigen increased Risk?
DACOMITINIB vs DACTINOMYCIN
DACOMITINIB vs DALBAVANCIN
DACOMITINIB vs DALFAMPRIDINE
DACOMITINIB vs DALTEPARIN
DACOMITINIB vs DAMOCTOCOG ALFA PEGOL